1. Volume 247, Pages 130-138 (January 2017)
Lifetime antipsychotic medication and cognitive performance in schizophrenia at age 43 years in a general population birth cohort 
Anja P. Husa, Jani Moilanen, Graham K. Murray, Riikka Marttila, Marianne Haapea, Irina Rannikko, Jennifer H. Barnett, Peter B. Jones, Matti Isohanni, Anne M. Remes, Hannu Koponen, Jouko Miettunen, Erika Jääskeläinen 
Psychiatry Research 
Volume 247, Pages (January 2017)
DOI: /j.psychres
Copyright © 2016 The Authors Terms and Conditions

2. Fig. 1
The association between lifetime dose-years of any antipsychotics and cognitive composite score at age 43 years in schizophrenia. Higher lifetime antipsychotic dose-years associated with poorer cognitive composite score. (Beta coefficient and statistical significance are from linear regression analysis with natural logarithm of dose-years of any antipsychotics as the predictor variable).
Psychiatry Research  , DOI: ( /j.psychres )
Copyright © 2016 The Authors Terms and Conditions